Science News
from research organizations

Key to making cancer-killing peptides

Date:
June 1, 2011
Source:
Aalto University
Summary:
Researchers have found the mechanism of action for cancer-cell-killing peptides. This research is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria. Thanks to this new knowledge, it is hoped that future medical therapies will be more effective and have far fewer side effects. The first trials on patients are expected to take place over the next two years and the first finished products should be entering the market ten years from now.
Share:
         
Total shares:  
FULL STORY

Professor Paavo Kinnunen.
Credit: Image courtesy of Aalto University

Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria. Thanks to this new knowledge, it is hoped that future medical therapies will be more effective and have far fewer side effects. The first trials on patients are expected to take place over the next two years and the first finished products should be entering the market ten years from now.

The research has focused on peptides which target and lethally harm cancer cells. Cytotoxic peptides are short chains of amino acids that are able to penetrate and damage the lipid membrane surrounding individual cancer cells. By manipulating this response, researchers hope to cause cancer cells to die off and leave all other cells unharmed.

"Our research has shown that the mechanism by which these life-saving peptides trigger cell-death is similar to that utilized by peptides which are the culprit of certain neurodegenerative diseases," explains Professor Paavo Kinnunen, whose research team at the Department of Biomedical Engineering has made the breakthrough. The mechanism is similar, yet the effects are polar opposites -- either beneficial or lethal. Hence, the research results reached by Kinnunen and his team may affect not only the treatment of cancer but also the current understanding of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases and their treatment.

Professor Kinnunen and his team have worked on cytotoxic peptides for a number of years. Interest in the topic is shared by research groups in many other universities, and other researchers have been able to confirm results reached by Kinnunen and his team.


Story Source:

The above story is based on materials provided by Aalto University. Note: Materials may be edited for content and length.


Cite This Page:

Aalto University. "Key to making cancer-killing peptides." ScienceDaily. ScienceDaily, 1 June 2011. <www.sciencedaily.com/releases/2011/05/110526091305.htm>.
Aalto University. (2011, June 1). Key to making cancer-killing peptides. ScienceDaily. Retrieved April 27, 2015 from www.sciencedaily.com/releases/2011/05/110526091305.htm
Aalto University. "Key to making cancer-killing peptides." ScienceDaily. www.sciencedaily.com/releases/2011/05/110526091305.htm (accessed April 27, 2015).

Share This Page:


Health & Medicine News
April 27, 2015

Latest Headlines
updated 12:56 pm ET